Notice Information
Notice Title
Compounded mAbs - Cancer Therapies
Notice Description
Phamacy Procurement Contract - A ranked framework for the supply and delivery of Compounded Monoclonal Antibodies (mAbs) for Intravenous Infusion for Chemotherapy indications split into 2 lots: Lot 1: High Volume Products - 5 molecules / all brands Lot 2: Lower Volume Products - 13 molecules / all brands The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS): Thames Valley and Wessex (TV&W) 1. Buckinghamshire Healthcare NHS Trust 2. Frimley Health NHS Foundation Trust 3. Hampshire Hospitals NHS Foundation Trust 4. Isle of Wight NHS Trust 5. Hampshire and Isle of Wight Healthcare NHS Foundation Trust 6. Milton Keynes University Hospital NHS Foundation Trust 7. Oxford Health NHS Foundation Trust 8. Oxford University Hospitals NHS Foundation Trust 9. Portsmouth Hospitals NHS Trust 10. Royal Berkshire NHS Foundation Trust 11. University Hospital Southampton NHS Foundation Trust South-East Coast (SEC) 12. Ashford and St. Peters' Hospitals NHS Foundation Trust 13. Dartford and Gravesham NHS Trust 14. East Kent Hospitals University NHS Foundation Trust 15. East Sussex Healthcare NHS Trust 16. Kent Community Health NHS Trust 17. Maidstone & Tunbridge Wells NHS Trust 18. Medway NHS Foundation Trust 19. Queen Victoria Hospitals NHS Foundation Trust 20. Royal Surrey County Hospital NHS Foundation Trust 21. Surrey and Borders Partnership NHS Foundation Trust 22. Surrey and Sussex Healthcare NHS Trust 23. Sussex Community NHS Trust 24. Sussex Partnership NHS Foundation Trust 25. University Hospitals Sussex NHS Foundation Trust 26. Berkshire Healthcare NHS Foundation Trust This framework will be available for use by Trusts in East of England and London regions, but the volumes for these regions have not been included for adjudication as part of the tender process. SEC Trusts can utilise this tender for products or services not covered by the National unlicensed aseptically prepared cytotoxic medicines and mAbs framework via MPSC. Please note: we did not publish a preliminary market engagement notice (UK2) for the following reasons: - we are not seeking to further develop our requirements or procurement approach. - we have procured similar supply arrangements via the Open procedure and deployed similar conditions of participation and award criteria. These have yielded good results previously. - we have already prepared our tender pack (see attached), that detail standard NHS contractual terms which have been found to be acceptable to the supply chain. - we understand the likely suppliers who will be interested but the open notice approach gives opportunity to others looking to enter the mAbs supply market
Lot Information
Lot 1
High Volume Products - 5 molecules / all brands
Options: Option for 2 x 12 month extension (maximum duration 4 years).
Renewal: Option for 2 x 12 month extension (maximum duration 4 years).
Lot 2Lower Volume Products - 13 molecules / all brands
Options: Option for 2 x 12 month extension (maximum duration 4 years).
Renewal: Option for 2 x 12 month extension (maximum duration 4 years).
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-0693de
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/043323-2026
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- UK4 - Tender Notice
- Procurement Type
- Framework
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- SME, VCSE
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
85 - Health and social work services
-
- CPV Codes
33600000 - Pharmaceutical products
85149000 - Pharmacy services
Notice Value(s)
- Tender Value
- £216,000,000 £100M-£1B
- Lots Value
- £216,000,000 £100M-£1B
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 12 May 20262 days ago
- Submission Deadline
- 22 Jun 20262 months to go
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- 1 Dec 2026 - 30 Nov 2028 2-3 years
- Recurrence
- 2029-07-02
Notice Status
- Tender Status
- Active
- Lots Status
- Active
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- BERKSHIRE HEALTHCARE NHS FOUNDATION TRUST
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- BRACKNELL
- Postcode
- RG12 2UT
- Post Town
- Reading
- Country
- England
-
- Major Region (ITL 1)
- TLJ South East (England)
- Basic Region (ITL 2)
- TLJ1 Berkshire, Buckinghamshire and Oxfordshire
- Small Region (ITL 3)
- TLJ15 Berkshire East
- Delivery Location
- TLJ South East (England)
-
- Local Authority
- Bracknell Forest
- Electoral Ward
- Bullbrook
- Westminster Constituency
- Bracknell
Further Information
Notice Documents
-
https://www.find-tender.service.gov.uk/Notice/043323-2026
12th May 2026 - Tender notice on Find a Tender -
https://www.find-tender.service.gov.uk/Notice/042148-2026
7th May 2026 - Tender notice on Find a Tender
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-0693de-2026-05-12T09:47:36+01:00",
"date": "2026-05-12T09:47:36+01:00",
"ocid": "ocds-h6vhtk-0693de",
"initiationType": "tender",
"parties": [
{
"id": "GB-PPON-PVLX-5425-VJZN",
"name": "Berkshire Healthcare NHS Foundation Trust",
"identifier": {
"scheme": "GB-PPON",
"id": "PVLX-5425-VJZN"
},
"address": {
"streetAddress": "London House, London Road",
"locality": "Bracknell",
"postalCode": "RG12 2UT",
"country": "GB",
"countryName": "United Kingdom",
"region": "UKJ11"
},
"contactPoint": {
"name": "Neelan Moodley",
"email": "neelan.moodley@berkshire.nhs.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.berkshirehealthcare.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
}
}
],
"buyer": {
"id": "GB-PPON-PVLX-5425-VJZN",
"name": "Berkshire Healthcare NHS Foundation Trust"
},
"tender": {
"id": "PR BHFT 0715",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"title": "Compounded mAbs - Cancer Therapies",
"description": "Phamacy Procurement Contract - A ranked framework for the supply and delivery of Compounded Monoclonal Antibodies (mAbs) for Intravenous Infusion for Chemotherapy indications split into 2 lots: Lot 1: High Volume Products - 5 molecules / all brands Lot 2: Lower Volume Products - 13 molecules / all brands The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS): Thames Valley and Wessex (TV&W) 1. Buckinghamshire Healthcare NHS Trust 2. Frimley Health NHS Foundation Trust 3. Hampshire Hospitals NHS Foundation Trust 4. Isle of Wight NHS Trust 5. Hampshire and Isle of Wight Healthcare NHS Foundation Trust 6. Milton Keynes University Hospital NHS Foundation Trust 7. Oxford Health NHS Foundation Trust 8. Oxford University Hospitals NHS Foundation Trust 9. Portsmouth Hospitals NHS Trust 10. Royal Berkshire NHS Foundation Trust 11. University Hospital Southampton NHS Foundation Trust South-East Coast (SEC) 12. Ashford and St. Peters' Hospitals NHS Foundation Trust 13. Dartford and Gravesham NHS Trust 14. East Kent Hospitals University NHS Foundation Trust 15. East Sussex Healthcare NHS Trust 16. Kent Community Health NHS Trust 17. Maidstone & Tunbridge Wells NHS Trust 18. Medway NHS Foundation Trust 19. Queen Victoria Hospitals NHS Foundation Trust 20. Royal Surrey County Hospital NHS Foundation Trust 21. Surrey and Borders Partnership NHS Foundation Trust 22. Surrey and Sussex Healthcare NHS Trust 23. Sussex Community NHS Trust 24. Sussex Partnership NHS Foundation Trust 25. University Hospitals Sussex NHS Foundation Trust 26. Berkshire Healthcare NHS Foundation Trust This framework will be available for use by Trusts in East of England and London regions, but the volumes for these regions have not been included for adjudication as part of the tender process. SEC Trusts can utilise this tender for products or services not covered by the National unlicensed aseptically prepared cytotoxic medicines and mAbs framework via MPSC. Please note: we did not publish a preliminary market engagement notice (UK2) for the following reasons: - we are not seeking to further develop our requirements or procurement approach. - we have procured similar supply arrangements via the Open procedure and deployed similar conditions of participation and award criteria. These have yielded good results previously. - we have already prepared our tender pack (see attached), that detail standard NHS contractual terms which have been found to be acceptable to the supply chain. - we understand the likely suppliers who will be interested but the open notice approach gives opportunity to others looking to enter the mAbs supply market",
"status": "active",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
{
"scheme": "CPV",
"id": "85149000",
"description": "Pharmacy services"
}
],
"deliveryAddresses": [
{
"region": "UK",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKJ",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UK",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKJ",
"country": "GB",
"countryName": "United Kingdom"
}
],
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
{
"scheme": "CPV",
"id": "85149000",
"description": "Pharmacy services"
}
],
"deliveryAddresses": [
{
"region": "UK",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKJ",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UK",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UKJ",
"country": "GB",
"countryName": "United Kingdom"
}
],
"relatedLot": "2"
}
],
"value": {
"amountGross": 259200000,
"amount": 216000000,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"mainProcurementCategory": "services",
"aboveThreshold": true,
"techniques": {
"hasFrameworkAgreement": true,
"frameworkAgreement": {
"method": "withoutReopeningCompetition",
"type": "open",
"buyerCategories": "The ranked framework will be open to the participating Trusts of the South East Pharmacy Procurement Service (SEPPS). See Contract Description.",
"description": "The Contracting Authorities reserve the right to maintain supply with the incumbent Supplier to maintain continuity of care for patients. Framework call-off rules require the highest ranked Supplier for each LOT will be approached first to provide Services. Only should the highest ranked Supplier not be able to meet the demand and provide an acceptable product, will the next highest ranked Supplier be approached."
}
},
"submissionMethodDetails": "https://health-family.force.com/s/Welcome",
"submissionTerms": {
"electronicSubmissionPolicy": "allowed",
"languages": [
"en"
]
},
"tenderPeriod": {
"endDate": "2026-06-22T12:00:00+01:00"
},
"enquiryPeriod": {
"endDate": "2026-06-16T12:00:00+01:00"
},
"awardPeriod": {
"endDate": "2026-11-16T23:59:59Z"
},
"lots": [
{
"id": "1",
"title": "Lot 1",
"description": "High Volume Products - 5 molecules / all brands",
"status": "active",
"value": {
"amountGross": 204768000,
"amount": 170640000,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Procurement Specific Questionnaire",
"description": "Pass/Fail - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 0.01,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Framework Agreement T&Cs Acceptance",
"description": "Pass/Fail - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 0.01,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Technical Compliance/ Technical Capability/ Quality Assurance (40%)",
"description": "Technical Compliance / Technical Capability/ Quality Assurance. Responses to Technical Questions - see Tender Pack - ITT Instructions for detail. Note: MHRA Licensing is Pass/Fail",
"numbers": [
{
"number": 39.98,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Social Value (10%)",
"description": "Responses to Social Value Questions - see Tender Pack - ITT Instructions for detail.",
"numbers": [
{
"number": 10,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Shelf Life (15%)",
"description": "Shelf Life Assessment - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 15,
"weight": "percentageExact"
}
]
},
{
"type": "price",
"name": "Price (35%)",
"description": "Assessment of Pricing Model - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 35,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Procurement Specific Questionnaire",
"description": "Pass/Fail - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 0.01,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Framework Agreement T&Cs Acceptance",
"description": "Pass/Fail - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 0.01,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Technical Compliance/ Technical Capability/ Quality Assurance (40%)",
"description": "Technical Compliance / Technical Capability/ Quality Assurance. Responses to Technical Questions - see Tender Pack - ITT Instructions for detail. Note: MHRA Licensing is Pass/Fail",
"numbers": [
{
"number": 39.98,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Social Value (10%)",
"description": "Responses to Social Value Questions - see Tender Pack - ITT Instructions for detail.",
"numbers": [
{
"number": 10,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Shelf Life (15%)",
"description": "Shelf Life Assessment - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 15,
"weight": "percentageExact"
}
]
},
{
"type": "price",
"name": "Price (35%)",
"description": "Assessment of Pricing Model - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 35,
"weight": "percentageExact"
}
]
}
]
},
"selectionCriteria": {
"criteria": [
{
"type": "economic",
"description": "See Tender Pack"
},
{
"type": "technical",
"description": "See Tender Pack"
},
{
"type": "economic",
"description": "See Tender Pack"
},
{
"type": "technical",
"description": "See Tender Pack"
}
]
},
"suitability": {
"sme": true,
"vcse": true
},
"contractPeriod": {
"startDate": "2026-12-01T00:00:00Z",
"endDate": "2028-11-30T23:59:59Z",
"maxExtentDate": "2030-11-30T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "Option for 2 x 12 month extension (maximum duration 4 years)."
},
"hasOptions": true,
"options": {
"description": "Option for 2 x 12 month extension (maximum duration 4 years)."
}
},
{
"id": "2",
"title": "Lot 2",
"description": "Lower Volume Products - 13 molecules / all brands",
"status": "active",
"value": {
"amountGross": 54432000,
"amount": 45360000,
"currency": "GBP"
},
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Procurement Specific Questionnaire",
"description": "Pass/Fail - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 0.01,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Framework Agreement T&Cs Acceptance",
"description": "Pass/Fail - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 0.01,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Technical Compliance/ Technical Capability/ Quality Assurance (40%)",
"description": "Technical Compliance / Technical Capability/ Quality Assurance. Responses to Technical Questions - see Tender Pack - ITT Instructions for detail. Note: MHRA Licensing is Pass/Fail",
"numbers": [
{
"number": 39.98,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Social Value (10%)",
"description": "Responses to Social Value Questions - see Tender Pack - ITT Instructions for detail.",
"numbers": [
{
"number": 10,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Shelf Life (15%)",
"description": "Shelf Life Assessment - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 15,
"weight": "percentageExact"
}
]
},
{
"type": "price",
"name": "Price (35%)",
"description": "Assessment of Pricing Model - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 35,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Procurement Specific Questionnaire",
"description": "Pass/Fail - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 0.01,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Framework Agreement T&Cs Acceptance",
"description": "Pass/Fail - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 0.01,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Technical Compliance/ Technical Capability/ Quality Assurance (40%)",
"description": "Technical Compliance / Technical Capability/ Quality Assurance. Responses to Technical Questions - see Tender Pack - ITT Instructions for detail. Note: MHRA Licensing is Pass/Fail",
"numbers": [
{
"number": 39.98,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Social Value (10%)",
"description": "Responses to Social Value Questions - see Tender Pack - ITT Instructions for detail.",
"numbers": [
{
"number": 10,
"weight": "percentageExact"
}
]
},
{
"type": "quality",
"name": "Shelf Life (15%)",
"description": "Shelf Life Assessment - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 15,
"weight": "percentageExact"
}
]
},
{
"type": "price",
"name": "Price (35%)",
"description": "Assessment of Pricing Model - see Tender Pack - ITT Instructions for detail",
"numbers": [
{
"number": 35,
"weight": "percentageExact"
}
]
}
]
},
"selectionCriteria": {
"criteria": [
{
"type": "economic",
"description": "See Tender Pack"
},
{
"type": "technical",
"description": "See Tender Pack"
},
{
"type": "economic",
"description": "See Tender Pack"
},
{
"type": "technical",
"description": "See Tender Pack"
}
]
},
"suitability": {
"sme": true,
"vcse": true
},
"contractPeriod": {
"startDate": "2026-12-01T00:00:00Z",
"endDate": "2028-11-30T23:59:59Z",
"maxExtentDate": "2030-11-30T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "Option for 2 x 12 month extension (maximum duration 4 years)."
},
"hasOptions": true,
"options": {
"description": "Option for 2 x 12 month extension (maximum duration 4 years)."
}
}
],
"documents": [
{
"id": "A-15858",
"documentType": "biddingDocuments",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-15858",
"format": "application/x-zip-compressed"
},
{
"id": "conflictOfInterest",
"documentType": "conflictOfInterest"
},
{
"id": "042148-2026",
"documentType": "tenderNotice",
"noticeType": "UK4",
"description": "Tender notice on Find a Tender",
"url": "https://www.find-tender.service.gov.uk/Notice/042148-2026",
"datePublished": "2026-05-07T16:42:25+01:00",
"format": "text/html"
},
{
"id": "043323-2026",
"documentType": "tenderNotice",
"noticeType": "UK4",
"description": "Tender notice on Find a Tender",
"url": "https://www.find-tender.service.gov.uk/Notice/043323-2026",
"datePublished": "2026-05-12T09:47:36+01:00",
"format": "text/html"
}
],
"hasRecurrence": true,
"recurrence": {
"dates": [
{
"startDate": "2029-07-02T23:59:59+01:00"
},
{
"startDate": "2029-07-02T23:59:59+01:00"
}
]
},
"contractTerms": {
"financialTerms": "30 day payment terms as set out in the Tender Pack - see 'PR BHFT 0715 - ITT Open - Schedule 7 - Draft Contract'."
},
"riskDetails": "The following have been identified as 'Known Risks': Denial of access to raw material medicines to Suppliers, which increases the cost of mAb compounds, dose bands or brands on the Framework Agreement. Where this can be demonstrated by the Supplier, the Price for affected mAbs will be agreed and the Framework Prices modified as a Variation which may result in the overall Framework Agreement value increasing.",
"amendments": [
{
"id": "043323-2026",
"description": "Change to tender period resulting in the following alteration: Enquiry deadline change to 16/06/2026, 12.00pm Tender submission deadline change to 22/06/26, 12.00pm"
}
]
},
"language": "en"
}